Latest From Our Blog
For years, healthcare M&A valuations—particularly in home health, hospice, and related sectors—were driven by a familiar set of factors: growth rate, referral relationships,compliance, and geographic footprint. Those still matter. But in 2026, there’s a more decisive force shaping deal outcomes: Medicare reimbursement. Not in theory—but in how buyers interpret risk, structure deals, and ultimately determine […]
View all posts